Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-Controlled, Randomized Trial of Ensitrelvir (S-217622) for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)

NCT06161688 is registered in ClinicalTrials.gov with Timothy Henrich as lead sponsor.

NCT NCT06161688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06161688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-Controlled, Randomized Trial of Ensitrelvir (S-217622) for Viral Persistence and Inflammation in People Experiencing Long COVID (PREVAIL-LC)
Lead sponsor
Timothy Henrich
Phase
Phase 2
Overall status
Active, not recruiting
Start date
April 9, 2024
Completion date
December 31, 2026
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

long covid, post acute sequelae of covid-19, post-acute covid-19